Support of a molecular tumour board by an evidence-based decision management system for precision oncology

Reliable and reproducible interpretation of molecular aberrations constitutes a bottleneck of precision medicine. Evidence-based decision management systems may improve rational therapy recommendations. To cope with an increasing amount of complex molecular data in the clinical care of patients with cancer, we established a workflow for the interpretation of molecular analyses.

Source: European Journal of Cancer - January 22, 2020 Category: Cancer & Oncology Authors: Mario Lamping, Manuela Benary, Serge Leyvraz, Clemens Messerschmidt, Eric Blanc, Thomas Kessler, Moritz Sch ütte, Dido Lenze, Korinna Jöhrens, Susen Burock, Konrad Klinghammer, Sebastian Ochsenreither, Christine Sers, Reinhold Schäfer, Ingeborg Tinhofe Tags: Original Research Source Type: research